---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-24-049197"
form_type: "8-K"
ticker: "BPTH"
cik: "0001133818"
company_name: "BIO-PATH HOLDINGS, INC."
filed_at: "2024-04-19T23:59:59+00:00"
generated_at: "2026-06-03T15:13:33.552121+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# Bio-Path Holdings raises $1.2M in registered direct offering and warrants

## Summary
- Sold 375,000 shares at $3.225 per share for gross proceeds of $1.2 million.
- Concurrent private placement of warrants to purchase 375,000 shares at $3.10 per share.
- Net proceeds of ~$1.0M after fees; intended for working capital and general purposes.
- Offering expected to close April 19, 2024; H.C. Wainwright acted as placement agent.
- Outstanding shares will increase from 1,190,306 to 1,565,306 post-closing.

## SEC filing metadata
- accession: 0001104659-24-049197
- form_type: 8-K
- ticker: BPTH
- cik: 0001133818
- company_name: BIO-PATH HOLDINGS, INC.
- filed_at: 2024-04-19T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 1.01, 3.02, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1133818/000110465924049197/0001104659-24-049197-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1133818/000110465924049197/tm2412201d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-24-049197
- JSON: https://secwatch.observer/filing/0001104659-24-049197.json
- Plain text: https://secwatch.observer/filing/0001104659-24-049197.txt

## Key facts
- Material Agreements
  BIO-PATH HOLDINGS, INC. entered into Purchase Agreement with certain institutional investors valued at approximately $1.2 million (effective 2024-04-18).
  - Action: entry
  - Agreement: equity purchase
  - Counterparty: certain institutional investors
  - Value: approximately $1.2 million
  - Effective: 2024-04-18
  source text: On April 18, 2024, Bio-Path Holdings, Inc. (the “Company”) entered into a securities purchase agreement (the “Purchase Agreement”) with certain institutional investors, pursuant to which the Company agreed to sell, in a registered direct offering (the “Registered Direct Offering”), an aggregate of 375,000 shares (the “Shares”) of its common stock, par value $0.001 per share (“Common Stock”), for a purchase price per Share of $3.225 and gross proceeds of approximately $1.2 million.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1133818/000110465924049197/0001104659-24-049197-index.htm
- Material Agreements
  BIO-PATH HOLDINGS, INC. entered into Engagement Letter with H.C. Wainwright & Co., LLC (effective 2024-03-22).
  - Action: entry
  - Agreement: underwriting
  - Counterparty: H.C. Wainwright & Co., LLC
  - Effective: 2024-03-22
  source text: On March 22, 2024, the Company entered into an engagement letter (the “Engagement Letter”) with H.C. Wainwright & Co., LLC (the “Placement Agent”).
  evidence_url: https://www.sec.gov/Archives/edgar/data/1133818/000110465924049197/0001104659-24-049197-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.